Myocarditis in auto-immune or auto-inflammatory diseases

Autoimmunity Reviews

Volumn 16, Issue 8, 2017, Pages 811-816

  Comarmond, Cloé ^a,b,c,d   Cacoub, Patrice ^a,b,c,d  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^b SORBONNE UNIVERSITÉ   (France)

^c Sorbonne Université   (France)

^d CNRS   (France)

Author keywords

Autoimmune diseases; Myocarditis

Indexed keywords

ANTIPHOSPHOLIPID SYNDROME; ANTISYNTHETASE SYNDROME; AORTIC ARCH SYNDROME; AUTOIMMUNE DISEASE; AUTOINFLAMMATORY DISEASE; BEHCET DISEASE; CYOGLOBULINEMIA VASCULITIS; EOSINOPHILIC GRANULOMA; HUMAN; MIXED CONNECTIVE TISSUE DISEASE; MYOCARDITIS; REVIEW; SARCOIDOSIS; SYSTEMIC LUPUS ERYTHEMATOSUS; SYSTEMIC SCLEROSIS; ANIMAL; COMPLICATION; CONGESTIVE CARDIOMYOPATHY; CONNECTIVE TISSUE DISEASE; HEREDITARY PERIODIC FEVER; MYOSITIS; VASCULAR DISEASE;

ANIMALS; AUTOIMMUNE DISEASES; CARDIOMYOPATHY, DILATED; CONNECTIVE TISSUE DISEASES; HEREDITARY AUTOINFLAMMATORY DISEASES; HUMANS; LUPUS ERYTHEMATOSUS, SYSTEMIC; MYOCARDITIS; MYOSITIS; SARCOIDOSIS; VASCULAR DISEASES;

EID: 85020129981     PISSN: 15689972     EISSN: 18730183     Source Type: Journal    
DOI: 10.1016/j.autrev.2017.05.021     Document Type: Review

References (53)

1. Eckart, R.E., Scoville, S.L., Campbell, C.L., Shry, E.A., Stajduhar, K.C., Potter, R.N., et al. Sudden death in young adults: a 25-year review of autopsies in military recruits. Ann Intern Med 141 (2004), 829–834.
2. McCarthy, R.E., Boehmer, J.P., Hruban, R.H., Hutchins, G.M., Kasper, E.K., Hare, J.M., et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 342 (2000), 690–695.
3. Arbustini, E., Gavazzi, A., Dal Bello, B., Morbini, P., Campana, C., Diegoli, M., et al. Ten-year experience with endomyocardial biopsy in myocarditis presenting with congestive heart failure: frequency, pathologic characteristics, treatment and follow-up. G Ital Cardiol 27 (1997), 209–223.
4. Yilmaz, A., Ferreira, V., Klingel, K., Kandolf, R., Neubauer, S., Sechtem, U., Role of cardiovascular magnetic resonance imaging (CMR) in the diagnosis of acute and chronic myocarditis. Heart Fail Rev 18 (2013), 747–760.
5. Mavrogeni, S., Dimitroulas, T., Sfikakis, P.P., Kitas, G.D., Heart involvement in rheumatoid arthritis: multimodality imaging and the emerging role of cardiac magnetic resonance. Semin Arthritis Rheum 43 (2013), 314–324.
6. Johns, C.J., Michele, T.M., The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 78 (1999), 65–111.
7. Smedema, J.-P., Truter, R., de Klerk, P.A., Zaaiman, L., White, L., Doubell, A.F., Cardiac sarcoidosis evaluated with gadolinium-enhanced magnetic resonance and contrast-enhanced 64-slice computed tomography. Int J Cardiol 112 (2006), 261–263.
8. Watanabe, E., Kimura, F., Nakajima, T., Hiroe, M., Kasai, Y., Nagata, M., et al. Late gadolinium enhancement in cardiac sarcoidosis: characteristic magnetic resonance findings and relationship with left ventricular function. J Thorac Imaging 28 (2013), 60–66.
9. Nunes, H., Freynet, O., Naggara, N., Soussan, M., Weinman, P., Diebold, B., et al. Cardiac sarcoidosis. Semin Respir Crit Care Med 31 (2010), 428–441.
10. Chapelon-Abric, C., de Zuttere, D., Duhaut, P., Veyssier, P., Wechsler, B., Huong, D.L.T., et al. Cardiac sarcoidosis: a retrospective study of 41 cases. Medicine (Baltimore) 83 (2004), 315–334.
11. Chapelon-Abric, C., Saadoun, D., Biard, L., Sene, D., Resche-Rigon, M., Hervier, B., et al. Long-term outcome of infliximab in severe chronic and refractory systemic sarcoidosis: a report of 16 cases. Clin Exp Rheumatol 33 (2015), 509–515.
12. Barnabe, C., McMeekin, J., Howarth, A., Martin, L., Successful treatment of cardiac sarcoidosis with infliximab. J Rheumatol 35 (2008), 1686–1687.
13. Uthman, I., Touma, Z., Khoury, M., Cardiac sarcoidosis responding to monotherapy with infliximab. Clin Rheumatol 26 (2007), 2001–2003.
14. Higashihara, M., Mori, M., Takeuchi, A., Ogita, T., Miyamoto, T., Okimoto, T., Myocarditis in Behcet's disease—a case report and review of the literature. J Rheumatol 9 (1982), 630–633.
15. Maeda, S., Tamura, A., Zaizen, H., Takahashi, N., Behçet's disease complicated by giant-cell myocarditis. Intern Med (Tokyo Jpn), 53, 2014, 1721.
16. Lakhanpal, S., Tani, K., Lie, J.T., Katoh, K., Ishigatsubo, Y., Ohokubo, T., Pathologic features of Behçet's syndrome: a review of Japanese autopsy registry data. Hum Pathol 16 (1985), 790–795.
17. Geri, G., Wechsler, B., Thi Huong, D.L., Isnard, R., Piette, J.-C., Amoura, Z., et al. Spectrum of cardiac lesions in Behçet disease: a series of 52 patients and review of the literature. Medicine (Baltimore) 91 (2012), 25–34.
18. Cottin, V., Bel, E., Bottero, P., Dalhoff, K., Humbert, M., Lazor, R., et al. Revisiting the systemic vasculitis in eosinophilic granulomatosis with polyangiitis (Churg-Strauss): a study of 157 patients by the Groupe d'Etudes et de Recherche sur les Maladies Orphelines Pulmonaires and the European Respiratory Society Taskforce on eosinophilic granulomatosis with polyangiitis (Churg-Strauss). Autoimmun Rev 16 (2017), 1–9.
19. Courand, P.-Y., Croisille, P., Khouatra, C., Cottin, V., Kirkorian, G., Bonnefoy, E., Churg-Strauss syndrome presenting with acute myocarditis and cardiogenic shock. Heart Lung Circ 21 (2012), 178–181.
20. Guillevin, L., Pagnoux, C., Seror, R., Mahr, A., Mouthon, L., Le Toumelin, P., The Five-Factor Score revisited: assessment of prognoses of systemic necrotizing vasculitides based on the French Vasculitis Study Group (FVSG) cohort. Medicine (Baltimore) 90 (2011), 19–27.
21. Shanks, M., Ignaszewski, A.P., Chan, S.Y., Allard, M.F., Churg-Strauss syndrome with myocarditis manifesting as acute myocardial infarction with cardiogenic shock: case report and review of the literature. Can J Cardiol 19 (2003), 1184–1188.
22. Qiao, L., Gao, D., A case report and literature review of Churg-Strauss syndrome presenting with myocarditis. Medicine (Baltimore), 95, 2016, e5080.
23. Comarmond, C., Pagnoux, C., Khellaf, M., Cordier, J.-F., Hamidou, M., Viallard, J.-F., et al. Eosinophilic granulomatosis with polyangiitis (Churg-Strauss): clinical characteristics and long-term followup of the 383 patients enrolled in the French Vasculitis Study Group cohort. Arthritis Rheum 65 (2013), 270–281.
24. Marmursztejn, J., Guillevin, L., Trebossen, R., Cohen, P., Guilpain, P., Pagnoux, C., et al. Churg-Strauss syndrome cardiac involvement evaluated by cardiac magnetic resonance imaging and positron-emission tomography: a prospective study on 20 patients. Rheumatology (Oxford, England) 52 (2013), 642–650.
25. Lupi-Herrera, E., Sánchez-Torres, G., Marcushamer, J., Mispireta, J., Horwitz, S., Vela, J.E., Takayasu's arteritis. Clinical study of 107 cases. Am Heart J 93 (1977), 94–103.
26. Mavrogeni, S., Manoussakis, M.N., Myocarditis and subclavian stenosis in Takayasu arteritis. Int J Cardiol 148 (2011), 223–224.
27. Comarmond, C., Cluzel, P., Toledano, D., Costedoat-Chalumeau, N., Isnard, R., Gaudric, J., et al. Findings of cardiac magnetic resonance imaging in asymptomatic myocardial ischemic disease in Takayasu arteritis. Am J Cardiol 113 (2014), 881–887.
28. Talwar, K.K., Chopra, P., Narula, J., Shrivastava, S., Singh, S.K., Sharma, S., et al. Myocardial involvement and its response to immunosuppressive therapy in nonspecific aortoarteritis (Takayasu's disease)—a study by endomyocardial biopsy. Int J Cardiol 21 (1988), 323–334.
29. Sharma, B.K., Jain, S., Radotra, B.D., An autopsy study of Takayasu arteritis in India. Int J Cardiol 66:Suppl. 1 (1998), S85–S90 [discussion S91].
30. Breinholt, J.P. III, Tristani-Firouzi, M., Bohnsack, J.F., Shaddy, R.E., Evidence for early vessel involvement in the dysfunctional myocardium of Takayasu's arteritis. Pediatr Cardiol 22 (2001), 74–76.
31. Takeda, N., Takahashi, T., Seko, Y., Maemura, K., Nakasone, H., Sakamoto, K., et al. Takayasu myocarditis mediated by cytotoxic T lymphocytes. Intern Med (Tokyo Jpn) 44 (2005), 256–260.
32. Talwar, K.K., Kumar, K., Chopra, P., Sharma, S., Shrivastava, S., Wasir, H.S., et al. Cardiac involvement in nonspecific aortoarteritis (Takayasu's arteritis). Am Heart J 122 (1991), 1666–1670.
33. Zawadowski, G.M., Klarich, K.W., Moder, K.G., Edwards, W.D., Cooper, L.T., A contemporary case series of lupus myocarditis. Lupus 21 (2012), 1378–1384.
34. Thomas, G., Cohen Aubart, F., Chiche, L., Haroche, J., Hié, M., Hervier, B., et al. Lupus myocarditis: initial presentation and longterm outcomes in a multicentric series of 29 patients. J Rheumatol 44 (2017), 24–32.
35. Appenzeller, S., Pineau, C.A., Clarke, A.E., Acute lupus myocarditis: clinical features and outcome. Lupus 20 (2011), 981–988.
36. Frustaci, A., Gentiloni, N., Caldarulo, M., Acute myocarditis and left ventricular aneurysm as presentations of systemic lupus erythematosus. Chest 109 (1996), 282–284.
37. Ueda, T., Mizushige, K., Aoyama, T., Tokuda, M., Kiyomoto, H., Matsuo, H., Echocardiographic observation of acute myocarditis with systemic lupus erythematosus. Jpn Circ J 64 (2000), 144–146.
38. Sherer, Y., Levy, Y., Shoenfeld, Y., Marked improvement of severe cardiac dysfunction after one course of intravenous immunoglobulin in a patient with systemic lupus erythematosus. Clin Rheumatol 18 (1999), 238–240.
39. Tamburino, C., Fiore, C.E., Foti, R., Salomone, E., Di Paola, R., Grimaldi, D.R., Endomyocardial biopsy in diagnosis and management of cardiovascular manifestations of systemic lupus erythematosus (SLE). Clin Rheumatol 8 (1989), 108–112.
40. Leung, M.C.H., Harper, R.W., Boxall, J., Extracorporeal membrane oxygenation in fulminant myocarditis complicating systemic lupus erythematosus. Med J Aust 176 (2002), 374–375.
41. Fernandes, F., Ramires, F.J.A., Arteaga, E., Ianni, B.M., Bonfá, E.S.D.O., Mady, C., Cardiac remodeling in patients with systemic sclerosis with no signs or symptoms of heart failure: an endomyocardial biopsy study. J Card Fail 9 (2003), 311–317.
42. Pieroni, M., De Santis, M., Zizzo, G., Bosello, S., Smaldone, C., Campioni, M., et al. Recognizing and treating myocarditis in recent-onset systemic sclerosis heart disease: potential utility of immunosuppressive therapy in cardiac damage progression. Semin Arthritis Rheum 43 (2014), 526–535.
43. Lundberg, I.E., Cardiac involvement in autoimmune myositis and mixed connective tissue disease. Lupus 14 (2005), 708–712.
44. Lash, A.D., Wittman, A.L., Quismorio, F.P., Myocarditis in mixed connective tissue disease: clinical and pathologic study of three cases and review of the literature. Semin Arthritis Rheum 15 (1986), 288–296.
45. Whitlow, P.L., Gilliam, J.N., Chubick, A., Ziff, M., Myocarditis in mixed connective tissue disease. Association of myocarditis with antibody to nuclear ribonucleoprotein. Arthritis Rheum 23 (1980), 808–815.
46. Marnach, M., VanWinter, J., Watson, W., Myocarditis: an unusual cause of postpartum fever in pregnancy complicated by antiphospholipid syndrome. Am J Perinatol 24 (2007), 405–408.
47. Rodríguez-Pintó, I., Moitinho, M., Santacreu, I., Shoenfeld, Y., Erkan, D., Espinosa, G., et al. Catastrophic antiphospholipid syndrome (CAPS): descriptive analysis of 500 patients from the international CAPS registry. Autoimmun Rev 15 (2016), 1120–1124.
48. Cacoub, P., Comarmond, C., Domont, F., Savey, L., Saadoun, D., Cryoglobulinemia vasculitis. Am J Med, 2015.
49. Terrier, B., Karras, A., Cluzel, P., Collet, J.-P., Sène, D., Saadoun, D., et al. Presentation and prognosis of cardiac involvement in hepatitis C virus-related vasculitis. Am J Cardiol 111 (2013), 265–272.
50. Sharma, K., Orbai, A.-M., Desai, D., Cingolani, O.H., Halushka, M.K., Christopher-Stine, L., et al. Brief report: antisynthetase syndrome-associated myocarditis. J Card Fail 20 (2014), 939–945.
51. Dieval, C., Deligny, C., Meyer, A., Cluzel, P., Champtiaux, N., Lefevre, G., et al. Myocarditis in patients with antisynthetase syndrome: prevalence, presentation, and outcomes. Medicine (Baltimore), 94, 2015, e798.
52. Schwartz, T., Diederichsen, L.P., Lundberg, I.E., Sjaastad, I., Sanner, H., Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open, 2, 2016, e000291.
53. Allanore, Y., Vignaux, O., Arnaud, L., Puéchal, X., Pavy, S., Duboc, D., et al. Effects of corticosteroids and immunosuppressors on idiopathic inflammatory myopathy related myocarditis evaluated by magnetic resonance imaging. Ann Rheum Dis 65 (2006), 249–252.